AtaiBeckley ATAI
NASDAQ ATAI
$7.39 +0.05 (+0.68%)
As of: Sep 4, 2026 · 3:59 PM EDT

AtaiBeckley (ATAI) Gains from Investment Securities (2020 - 2024)

AtaiBeckley (ATAI) posted Gains from Investment Securities of $3.8 million for Q2 2025, up 82.84% sequentially from $2.1 million in Q4 2024.

Analysis

AtaiBeckley (ATAI) Gains from Investment Securities (2020 - 2024) Analysis & Trends

AtaiBeckley has reported Gains from Investment Securities for 6 years, with the latest figure at $3.8 million in Q2 2025.

  • Quarterly Gains from Investment Securities changed N/A year-over-year to $3.8 million in Q2 2025, while the trailing twelve-month figure through Sep 2025 was $5.9 million (up 245.03% YoY) and the FY2024 annual result came in at $2.1 million, changed N/A from the prior year.
  • Gains from Investment Securities improved to $3.8 million in Q2 2025 per ATAI's latest filing, from $2.1 million in the prior quarter.
  • Over five years, Gains from Investment Securities peaked at $16.5 million in Q4 2022 and troughed at -$469000.0 in Q3 2021.
  • A 5-year average of $2.3 million and a median of $972000.0 in 2021 frame the typical range for Gains from Investment Securities.
  • The sharpest annual moves came in 2021 and 2022: Gains from Investment Securities sank 645.35% in 2021, then soared 4641.48% in 2022.
  • Over 5 years, Gains from Investment Securities stood at -$364000.0 in 2021, then jumped by 4641.48% to $16.5 million in 2022, then plunged by 99.65% to $58000.0 in 2023, then soared by 3477.59% to $2.1 million in 2024, then soared by 82.84% to $3.8 million in 2025.
  • According to Business Quant data, Gains from Investment Securities over the past three periods registered $3.8 million, $2.1 million, and $1.7 million for Q2 2025, Q4 2024, and Q1 2024 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 AtaiBeckley 1.61 Bn 1.61 Bn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2024 101,000.00
Jun 30, 2024 273,000.00
Mar 31, 2024 1.70 Mn
Dec 31, 2023 394,000.00
Sep 30, 2023 58,000.00
Jun 30, 2023 -76,000.00
Mar 31, 2023 1.03 Mn
Dec 31, 2022 1.33 Mn
Sep 30, 2022 -430,000.00
Jun 30, 2022 -95,000.00
Mar 31, 2022 5.60 Mn
Dec 31, 2021 49.12 Mn
Sep 30, 2021 -469,000.00
Jun 30, 2021 911,000.00
Mar 31, 2021 1.70 Mn
Dec 31, 2020 2.81 Mn
Sep 30, 2020 86,000.00
Jun 30, 2020 42,000.00